Quantcast

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014

April 22, 2014

LONDON, April 22, 2014 /PRNewswire/ — Reportbuyer.com has added a new market research report:

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/gastrointestinal_stromal_tumor_gist_global_clinical_trials_review.html

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014

Summary

GlobalData’s clinical trial report, “Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014″ provides data on the Gastrointestinal Stromal Tumor (GIST) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastrointestinal Stromal Tumor (GIST). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gastrointestinal Stromal Tumor (GIST). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Introduction 6
Gastrointestinal Stromal Tumor (GIST) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Gastrointestinal Stromal Tumor (GIST) 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Gastrointestinal Stromal Tumor (GIST) 35
Jun 11, 2013: Ariad Pharma Initiates Phase II Trial Of Ponatinib In Patients With Gastrointestinal Stromal Tumors 35
Nov 21, 2012: Regorafenib Overcomes Resistance In Patients With Gastrointestinal Stromal Tumor After Failure Of Standard Targeted Therapies, Researchers Report 35
Oct 24, 2012: EirGen Pharma’s Cancer Product Eir-108 Passes Clinical Trial In Japan 36
Jun 01, 2012: Clinical Trial Design Supports Original Accelerated Approval Of Sunitinib For GIST, Study Reports 36
Apr 03, 2012: Bayer Announces Positive Results From Phase III Trial Evaluating Regorafenib In Patients With Metastatic Gastrointestinal Stromal Tumors 37
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Novartis AG 39
Clinical Trial Overview of Novartis AG 39
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Bayer AG 45
Clinical Trial Overview of Bayer AG 45
AB Science 46
Clinical Trial Overview of AB Science 46
GlaxoSmithKline plc 47
Clinical Trial Overview of GlaxoSmithKline plc 47
Sarcoma Alliance for Research through Collaboration 48
Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration 48
Amgen Inc. 49
Clinical Trial Overview of Amgen Inc. 49
Infinity Pharmaceuticals, Inc. 50
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
AEterna Zentaris Inc. 52
Clinical Trial Overview of AEterna Zentaris Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
National Cancer Institute 53
Clinical Trial Overview of National Cancer Institute 53
European Organization for Research and Treatment of Cancer 56
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 56
The University of Texas M. D. Anderson Cancer Center 57
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 57
Stanford University 58
Clinical Trial Overview of Stanford University 58
Asan Medical Center 59
Clinical Trial Overview of Asan Medical Center 59
Radboud University 60
Clinical Trial Overview of Radboud University 60
Memorial Sloan Kettering Cancer Center 61
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 61
National University Hospital 62
Clinical Trial Overview of National University Hospital 62
Fox Chase Cancer Center 63
Clinical Trial Overview of Fox Chase Cancer Center 63
Technische Universitat Munchen 64
Clinical Trial Overview of Technische Universitat Munchen 64
Five Key Clinical Profiles 65
Appendix 160
Abbreviations 160
Definitions 160
Research Methodology 161
Secondary Research 161
About GlobalData 162
Contact Us 162
Disclaimer 162
Source 163

List of Tables

Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Gastrointestinal Stromal Tumor (GIST) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 39
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 43
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 45
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by AB Science, 2014* 46
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 47
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2014* 48
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 49
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2014* 50
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 51
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2014* 52
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 53
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 56
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 57
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 58
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014* 59
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014* 60
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 61
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Hospital, 2014* 62
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2014* 63
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Technische Universitat Munchen, 2014* 64

List of Figures
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Gastrointestinal Stromal Tumor (GIST) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 161

Read the full report:
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/gastrointestinal_stromal_tumor_gist_global_clinical_trials_review.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


Source: PR Newswire



comments powered by Disqus